NEVRO CORP.
NVRO
NVRO was delisted on the 2nd of April, 2025.
201 hedge funds and large institutions have $2.4B invested in NEVRO CORP. in 2017 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 89 increasing their positions, 46 reducing their positions, and 41 closing their positions.
93% more repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 46
22% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 41
4% more funds holding
Funds holding: 193 → 201 (+8)
14% less capital invested
Capital invested by funds: $2.8B → $2.4B (-$397M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
25% less call options, than puts
Call options by funds: $14.7M | Put options by funds: $19.6M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$114M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$51.4M |
| 3 |
Millennium Management
New York
|
+$51.3M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$41.4M |
| 5 |
Jennison Associates
New York
|
+$36.8M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$78.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$51.8M |
| 3 |
CCI
Columbus Circle Investors
|
-$47.5M |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$45.6M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$38.8M |
NVRO Hedge Fund Activity: Q2 2017 in Review
201 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NEVRO CORP. (NVRO) for Q2 2017, worth a combined $2.4B — down 14% from $2.8B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new NVRO positions and 41 closed out — a net gain of 9 holders — while 89 added to existing stakes and 46 trimmed.
The largest buyer was Janus Henderson Group, opening a new position worth an estimated $114M. The largest seller was Fidelity Investments, cutting an estimated $78.3M.
- 201 institutional investors held NEVRO CORP. (NVRO) as of Q2 2017, up from 193 in Q1 2017.
- Funds reported $2.4B of NEVRO CORP. stock for Q2 2017, down 14% quarter-over-quarter.
- 50 funds opened new NEVRO CORP. positions in Q2 2017 and 41 closed out, a net change of +9 holders.
- The largest NEVRO CORP. buyer in Q2 2017 was Janus Henderson Group, an estimated $114M added.
- The largest NEVRO CORP. seller in Q2 2017 was Fidelity Investments, an estimated $78.3M sold.
Based on aggregated 13F filings for Q2 2017.